Prevalence of renal disease in elderly hypertensive patients with cardiovascular problems

Coronary Artery Disease

Volumn 8, Issue 8-9, 1997, Pages 483-488

  Ruilope, Luis M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Antihypertensive therapy; Arterial hypertension; Microalbuminuria; Nephrosclerosis; Proteinuria; Renal function

Indexed keywords

CREATININE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; HUMAN; HYPERTENSION; MICROALBUMINURIA; MORBIDITY; MORTALITY; NEPHROSCLEROSIS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RENOVASCULAR DISEASE; REVIEW;

AGED; AGING; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FUNCTION TESTS; MALE; NEPHROSCLEROSIS; PREVALENCE; RISK FACTORS; SPAIN;

EID: 0030725904     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Lippman RH, Schatzke PD: Renal anatomy and nephropathology of aging. In Geriatric Nephrology and Urology. Edited by Zawad ETJ, Sica DA. Litlleton, Massachusetts: PSG; 1985:15-32.
2. McLachlan MSF. Boylan L: Structural-functional relationships in the aging kidney. Invest Radiol 1980, 15:413-418.
3. McLachlan M: Anatomic structural and vascular changes in the aging kidney. In Renal Function and Disease in the Elderly. Edited by Nunez JFM, Cameron JS. London: Butterworths; 1987:3-26.
4. Kasiske BL: Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987, 31:1153-1159.
5. Woollson RG, de Wardener HE: Primary renal abnormalities in hereditary hypertension. Kidney Int 1996, 50:717-731. This article contains a complete review of the renal abnormalities that could account for the development of hereditary arterial hypertension.
6. Ruilope LM, Lahera V, Rodicio JL, Romero JC. Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension 1994, 23:3-9.
7. Folkow B: Kidneys in primary hypertension: initiators, stabilizers and/or victim-aggravators? Blood Press 1994, 3:212-215.
8. Ruilope LM: How much does the kidney participate in the origin of primary hypertension? Blood Press 1994, 3:216-218.
9. Blackshear JL, Garnic D, Williams GH, Harrington DP, Holenberg NK: Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives on essential hypertensive subjects. Hypertension 1987, 9:384-389.
10. 0 Montanari A, Vallisa D, Ragni G, Guerra A, Colla R, Novarini A, Coruzzi P: Abnormal renal responses to calcium entry blockade in normotensive offspring of hypertensive parents. Hypertension 1988, 12:498-505.
11. Ramirez AJ, Giménez MI, Gallo G, Marco EJ, Sánchez RA: Renal sodium handling abnormalities in hypertensive and normotensive patients with a family history of hypertension. J Hypertens 1989, 7 (suppl 6):S178-S179
12. Ruilope LM, Campo C, Rodicio JL: Relationship between blood pressure and renal function. J Hypertens 1994, 12 (suppl 8):S55-S59.
13. Perera GA: Hypertensive vascular disease: description and natural history. J Chronic Dis 1995, 1:33-42.
14. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, et al: Blood pressure, stroke, and coronary heart disease, part II; effects of short-term reductions in blood pressure: an overview of the unconfounded randomised drug trials in an epidemiological context. Lancet 1990, 335:827-838.
15. Collins R, Peto R: Antihypertensive drug therapy: effects on stroke and coronary heart disease. In Textbook of Hypertension. Edited by Swales JD. Oxford: Blackwell Scientific Publications; 1994:1156-1164.
16. Weisstuch JM, Dworkin LD: Does essential hypertension cause end-stage renal failure? Kidney Int 1992, 41 (suppl 36):S33-S37.
17. Madhavan S, Stockwell D, Cohen H, Alderman MH: Renal function during antihypertensive treatment Lancet 1995, 345:749-751.
18. National Institute of Diabetes and Digestive and Kidney Diseases: US Renal Data System: Annual Data Report. Bethesda, Maryland: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; 1989.
19. Ruilope LM, Alcazar JM, Rodicio JL: Renal consequences of arterial hypertension. J Hypertens 1992, 10 (suppl 7):S85-S90.
20. Ruilope LM, Alcazar JM, Hernández E, Moreno F, Martinez MA, Rodicio JL: Does an adequate control of blood pressure protect the kidney in essential hypertension? J Hypertens 1990, 8:525-532.
21. Rostand SG, Brown G, Kirk K, Rutsky EA, Dustan HP: Renal insufficiency in treated essential hypertension. N Engl J Med 1989, 320:684-688.
22. Rosansky SJ, Hoover DR, King I, Gibson J: The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 1990, 150:2073-2076.
23. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M: A prospective study of blood pressure and serum creatinine: results from the Clue Study and the ARIC Study. JAMA 1993, 269:488-493.
24. Perneger TV, Klag MJ, Feldman HI, Whelton PK: Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA 1993, 269:1272-1277.
25. Samuelsson O: Hypertension in middle-aged man: management morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand 1985, 702 (suppl):1-79.
26. Rostand SG, Brunzell JD, Cannon RO, Victor RG: Cardiovascular complications in renal failure. J Am Soc Nephrol 1991, 2:1053-1058.
27. Shulman NB, Ford CE, Hall WD, Blaufox D, Simon D, Langford HG, Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension 1989, 13 (suppl I):180-193
28. Aronow WS: Usefulness of serum creatinine as a marker for coronary events in elderly patients with either systemic hypertension of diabetes mellitus. Am J Cardiol 1991, 68:476-477.
29. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E: Proteinuria and mortality in diabetes; the WHO Multinational Study of Vascular Disease in Diabetes. Diabetic Med 1995, 12:149-155.
30. Takazakura E, Sawabu N, Handa A, Takada A, Shinoda A, Takeuchi J: Intrarenal vascular changes with age and disease. Kidney Int 1972, 2:224-230.
31. Tracy RE, Bhandaru SY, Oalmann MC, Guzmán MA, Newman WP III: Blood pressure and nephrosclerosis in black and white men and women aged 25 to 54. Mod Pathol 1991, 4:602-609.
32. Tracy RE, Malcom GT, Oalmann MC, Newman WP III, Guzmán MA, Strong GP: Nephrosclerosis in coronary heart disease. Mod Pathol 1994, 7:301-309.
33. Tracy RE, Strong JP, Newman WP III, Malcom GT, Oalmann MC, Guzman MA: Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25-54 years. Kidney Int 1996, 49: 564-570. This paper shows the correlation between renal artenolar hyalinosis and coronary atherosclerosis in otherwise asymptomatic people.
34. Ruilope LM, Rodicio JL: Microalbuminuria in clinical practice. Kidney 1995, 4:211-216.
35. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987, 31:673-689.
36. Agrawal B, Berger A, Wolf K, Luft FC: Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996, 14:223-228.
37. Cerasola G, Cottone S, Mulé G, Nardi E, Mangano MT, Andronico G, et al.: Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996, 14: 921-926.
38. Ljingman S, Wikstrand J, Hartford M, Berglund G: Urinary albumin excretion: a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive man. Am J Hypertens 1996, 9:770-778. [36,37,38] Evidence showing that the presence of microalbuminuria is a good predictor of an increased cardiovascular risk are contained in these three papers.
39. Tierney WM, Harris LE, Copley JB, Luft FC: Effect of hypertension and type II diabetes on renal function in an urban population. Am J Hypertens 1990, 3:69-75.
40. Messerli FH, Fhrolich ED, Dreslinski GR, Suarez DH, Aristimuno CG: Serum uric acid in essential hypertension: an indicator of renal vascular involvement Ann Intern Med 1980, 93:817-821.
41. Reaven GM, Lithell H, Landsberg L: Mechanisms of disease: hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381. This is an excellent review on the contribution of insulin resistance to cardiovascular risk.
42. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST: Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995, 142:288-294. This paper presents evidence linking uric acid, insulin resistance and coronary atherosclerosis.
43. Ruilope LM, Alcazar JM, Hernandez E, Lahera V, Garcia-Robles R, Villa E, et al: Metabolic alterations accompanying essential hypertension are associated with nephrosclerosis (abstract). J Hypertens 1993, 11 (suppl 5):S475.
44. Dengel D, Goldberg AP, Mayuga RS, Kairis GM, Weir MR: Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996, 28:127-132. This paper shows the correlation between insulin resistance and progressive deterioration of renal function in hypertensive patients.
45. Toto RD, Mitchell HC, Smith RD, Lee HC, McIntire D, Pettinger WA: 'Strict' blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 1995, 48:851-859. This publication seems to indicate that renal outcome is not improved simply by stricter blood pressure control.
46. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al., for the Modification of Diet in Renal Disease (MDRD) Study: Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study. Ann Intern Med 1995, 123:754-762. In this study, a stricter control of blood pressure slowed the progression of chronic renal failure in patients with proteinuria in the nephrotic range.
47. Brazy PC, Stead WW, Fitzwilliam JF: Progression of renal insufficiency: role of blood pressure. Kidney Int 1989, 35:670-674.
48. Ruilope LM, Hansoon L, Zanchetti A, for the HOT Study Group: Renal aspects of the HOT Study. J Nephrol 1996, 9:147-151. Evidence reported in this paper suggests that adequate control of blood pressure can be attained in essential hypertension independently of the level of renal function.
49. Lewis EJ, Hunsicker LG, Bain RP, Ronde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.
50. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, et al., and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996, 334:939-945. This study presents the first evidence that angiotensin converting enzyme inhibitors can be useful in decreasing the velocity of renal function decay in non-diabetic nephropathies.
51. Ruilope LM, Alcazar JM, Hernandez E, Praga M, Lahera V, Rodicio JL: Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 1994, 45 (suppl 45):S171-S173.
52. Sihm I. Shroeder AP, Aalkjaer C, Holm M. Morn B, Mulvany M, et al: Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensinconverting enzyme inhibitor based regimen in hypertensive patients. Am J Cardiol 1995, 76:38E-40E.
53. Schiffrin EL, Deng LY: Comparison of the effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995; 25 (part 2):699-703.
54. Himmelmann A, Hansson L, Hansson BG, Hedstrand H, Skogström K, Öhrvik J, Furängen A: ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension. Blood Press 1995, 4:85-90.
55. Wollenweber J, Sheps SG, Davis GD: Clinical course of atherosclerotic renovascular disease. Am J Cardiol 1968, 91:60-71.
56. Meaney TF, Dustan HP, McCormack LJ: Natural history of renal artery disease. Radiology 1968, 91:881-887.
57. Dean RH, Foster JH: Criteria for the diagnosis of renovascular hypertension. Surgery 1973, 74:926-929.
58. Schreiber MJ, Pohl MA, Novick AC: The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984, 11:383-392.
59. Schwartz CJ, White TA: Stenosis of renal artery: an unselected necropsy study. BMJ 1964, 2:1415-1421.
60. Choudri AH, Cleland JGF, Rowlands PC, Tran TL. McCarthy M, AI-Kutoubi MA: Unsuspected renal artery stenosis in peripheral vascular disease. BMJ 1990, 301:1197-1198.
61. Loin JW, Melia M, Young JR, Graor RA, Risius B: Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990, 88:146N-151N.
62. Wilm G, Marchal G, Peene P, Baert AL: The angiographic incidence of renal artery stenosis in the atherosclerotic population. Eur J Radiol 1990, 10:195-197.
63. Schartbol P, Thorvinger BO, Parsson H, Norgreen L: Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension: a retrospective study. Int Angiol 1992, 11:195-199.
64. Harding MD, Smith LR, Himmelstein SI, Harnson K, Philip HR, Schwab SJ, el al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992, 2:1608-1614.
65. Dean RH, Kieffer RW, Smith BW: Renovascular hypertension anatomic and renal function changes during drug therapy. Arch Surg 1981. 116:1408-1415.
66. Scoble JE, Maher ER, Hamilton G, Dick R, Sweney P, Moorhead JF: Atherosclerotic renovascular disease causing renal impairment: a case for treatment. Clin Nephrol 1989, 31:119-122.
67. Khan IH, Catto GRD, Edward N, Flemming LW, Henderson IS, MacLeod AM: Influence of coexisting disease on survival on renal replacement therapy. Lancet 1993, 34:415-418.
68. Mailloux L, Napolitano B, Belluci G, Vernace M, Wilkes BM, Mossey RT: Renal vascular disease causing end-stage renal disease, incidence clinical correlates, and outcomes: a 20 year clinical experience. Am J Kidney Dis 1994, 24:622-629.
69. Alcazar JM, Carameio CA, Alegre ER, Abad J: Ischaemic renal injury. Curr Opin Nephrol Hypertens 1997, 6:157-165.
70. Harden PN, LacLeod MJ, Rodger RSC, Baxter GM. Connell JMC. Dominiczak AF, et al.: Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997, 349:1133-1136.